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A B S T R A C T
Objective: To assess the effects of maternal asthma on pregnancy, analyzing the conse-
quences of the severity of the disease in the impairment of fetal well-being, as well as the 
related maternal and perinatal complications. 
Methods: A retrospective study with 117 pregnancies complicated by maternal asthma and 
with no other comorbidities, in the period from January, 2005 to December, 2010. Inclusion 
criteria were as follows: singleton pregnancy; pregnant women diagnosed with asthma 
prior to pregnancy; initiation of prenatal care before the 28th week of pregnancy; birth at 
this institution; newborn weighing over 500 g and gestational age at delivery of 22 weeks or 
more; absence of fetal malformations or chromosomal abnormalities; absence of maternal 
comorbidities. Asthma was classified as intermittent, mild persistent, moderate persistent, 
or severe persistent. The results of fetal biophysical profile and of Doppler velocimetry of 
the umbilical artery performed 14 days prior to birth were analyzed. 
Results: Of the total of 117 pregnant women with asthma, 41 (35.0%) had intermittent, 33 
(28.2%) mild persistent, 21 (17.9%) moderate persistent, and 22 (18.8%) severe persistent 
asthma. There was no significant difference among the groups as to the type of birth: 
cesarean section was performed in 65.8% of the cases, maternal corticosteroid therapy was 
used at the moment of birth in 20.5%, the gestational age at birth averaged 38.6  weeks 
(SD 1.9 weeks), and birth weight averaged 3,056 g (SD 581g). The fetal biophysical profile 
performed during the antepartum period (n = 90, 76.9%) showed a normal result (8 or 10) 
in 99% of the cases. Doppler velocimetry of the umbilical artery was assessed in 23.9% 
(n = 28) of the pregnant women, and delivered normal results in 100% of the cases. The 
use of systemic corticosteroid therapy was significantly (p <  0.001) different among the 
intermittent (4.9%), mild persistent (9.1%), moderate persistent (28.6%), and severe 
persistent (45.5%) groups. Regarding the beginning of birth, there was a higher proportion 
of elective cesarean section in the groups with moderate persistent asthma (52.5%) and 
severe persistent (54.6%) when compared to the intermittent (21.9%) and mild persistent 
(24.2%) groups (p = 0.039). 
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Introduction
Literature describes different prevalences of asthma during 
pregnancy. In Canada, asthma affects only 0.43% of pregnant 
women,1 while in the United States this rate can reach 8.4%.2 In 
Brazil, although there are only few studies on the topic, it is 
estimated that the prevalence of asthma in the population is 
closer to U.S. patterns, ranging from 5% to 8%.3
Research on perinatal outcomes in pregnancy complicated 
by asthma shows higher perinatal morbidity,4,5 but few studies 
relate the severity of maternal asthma with impairment of 
fetal well-being. In a study published in 1992, fetal distress 
was an indication for cesarean section in 25% of the cases 
analyzed.6 Asthma is a pathology characterized by intermittent 
Conclusion: The severity of maternal asthma does not appear to have any direct influence 
on perinatal outcomes, and does not compromise fetal well-being. Active conduct to 
enable a better maternal clinical condition provides a favorable prognosis for pregnancy 
complicated by asthma.
Asma na gestação: efeitos na vitalidade fetal, complicações maternas  
e perinatais
R E S U M O
Objetivo: Avaliar os efeitos da asma materna sobre a gravidez, analisando as repercussões da 
gravidade da doença no comprometimento do bem-estar fetal, bem como as complicações 
maternas e perinatais associadas.
Métodos: Foi realizado estudo retrospectivo de 117  gestações complicadas pela asma 
materna e sem outras comorbidades, no período de janeiro de 2005 a dezembro de 2010. 
Os critérios de inclusão foram: gestação única; diagnóstico de asma prévio à gestação; 
início do pré-natal antes da 28a semana de gravidez; parto realizado na instituição; peso do 
recém-nascido acima de 500 g e idade gestacional no parto acima de 22 semanas; ausência 
de malformações fetais ou anomalias cromossômicas; ausência de comorbidades maternas. 
A gravidade da asma foi classificada em intermitente, persistente leve, persistente mode-
rada, persistente grave. Foram analisados os resultados do perfil biofísico fetal e da doppler-
velocimetria de artéria umbilical realizados até 14 dias antes do parto.
Resultados: Do total de 117 gestantes asmáticas analisadas: 41 (35,0%) eram intermitentes, 
33 (28,2%) persistentes leves, 21 (17,9%) persistentes moderadas e 22 (18,8%) persistentes 
graves. Não houve diferença significativa entre os grupos quanto ao tipo de parto: a cesárea 
foi realizada em 65,8% dos casos, a corticoterapia materna no momento do parto em 
20,5%, a idade gestacional no parto apresentou média de 38,6 semanas (DP 1,9 semanas) 
e o peso ao nascimento apresentou média de 3056  g (DP 581  g). O perfil biofísico fetal 
realizado no período anteparto (n = 90, 76,9%) apresentou resultado normal (8 ou 10) em 
99% dos casos. A dopplervelocimetria de artéria umbilical foi avaliada em 23,9% (n = 28) das 
gestantes, e apresentou-se normal em 100% dos casos. O uso de corticoterapia sistêmica 
foi significativamente (p < 0,001) diferente entre os grupos intermitente (4,9%) e persistente 
leve (9,1%), persistente moderada (28,6%), persistente grave (45,5%). Quanto ao início do 
parto, houve maior proporção de cesárea eletiva no grupo com asma persistente moderada 
(52,5%) e persistente grave (54,6%) quando comparados aos grupos intermitente (21,9%) e 
persistente leve (24,2%) (p = 0,039).
Conclusão: A gravidade da asma materna não parece influenciar diretamente os resultados 
perinatais e não compromete a vitalidade fetal. A conduta ativa proporcionando melhor 
quadro clínico materno promove evolução favorável para a gestação complicada pela asma.
Palavras-chave:
Gestação
Feto
Asma
Cesárea
Assistência perinatal
or persistent symptoms of bronchoconstriction, including: 
dyspnea, wheezing, cough, and chest tightness. The diagnosis 
is reached by analyzing the response to bronchodilator 
obtained through spirometry. It is may be clinically classified 
as intermittent, persistent, mild, moderate, or severe, pursuant 
to the types and frequency of symptoms shown by the patient 
and the results obtained in respiratory tests.
Asthma in pregnancy is deemed a high risk factor for 
pregnant women and their fetuses. Controlled studies have 
shown a significantly increased risk of complications in 
pregnant women with asthma, especially in those with 
poorly controlled asthma.7,8 These complications include: 
prematurity,9,10 low birth weight,11 preeclampsia,12,13 higher 
proportion of cesarean section delivery,14 and higher perinatal 
morbidity.5 Some hypotheses were raised to explain such 
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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complications, namely: 1) common etiology for uterine and 
bronchial hyperactivity, 2) hypoxia secondary to maternal 
asthma, 3) bioactive mediators released during an asthma 
attack, 4) medications used to treat asthma during pregnancy.15
This study presents the experience in prenatal care of 
pregnancies complicated by maternal asthma, and aims to 
assess its effects on pregnancy, by analyzing how the severity 
of the disease impairs fetal well-being, i.e., impairment on 
fetus oxygenation, as well as related maternal and perinatal 
complications.
Methods
This study was conducted in a tertiary level university 
hospital that attends to high-risk pregnancies. This was 
a retrospective and descriptive study that adopted the 
following inclusion criteria: pregnant women diagnosed with 
asthma prior to pregnancy; singleton pregnancy; initiation 
of prenatal care before the 28th week of pregnancy; birth 
at this institution; newborn weighing more than 500 g and 
gestational age at delivery of 22 weeks or more; absence of 
fetal malformations or chromosomal abnormalities; absence of 
maternal comorbidities; and prenatal care at the Lung Diseases 
and Prenatal Care Sector in the period from January, 2005 to 
December, 2010. The research project was approved by the 
institution’s research ethics committee under the number 
745/10.
Patients were chosen, and data collected included infor-
mation obtained through medical records and registers of 
births filed in the institution’s Section of Medical Files, as 
well as information obtained through consultation to the 
department’s computerized database.
117 pregnancies complicated by maternal asthma were 
assessed; data related to the population characteristics are 
presented in Table 1. Severity of asthma was classified based on 
the clinical protocol adopted in the institution.16 Thus, asthma 
was classified as intermittent, mild persistent, moderate 
persistent, or severe persistent. This classification is based on 
the following parameters: frequency of daytime symptoms, 
frequency of night-time symptoms, variation in maximal 
expiratory pressure (MEP), and forced expiratory volume in one 
second (FEV1). Patients showing daily symptoms up to twice a 
week, night-time symptoms up to twice a month, FEV1 ≥ 80% of 
the expected number, and/or variation in MEP lower than 20% 
were classified with intermittent asthma. Patients classified as 
mild persistent showed daily symptoms three or more times 
a week and less than once a day, night-time symptoms three 
or more times a month, FEV1 ≥ 80% of the expected number, 
and/or variation in MEP between 20% and 30%. Those classified 
as moderate persistent showed daily symptoms, night-time 
symptoms twice or more a week, FEV1 between 60% and 80% 
of the expected number, and/or variation in MEP higher than 
30%. And, finally, those showing persistent daily symptoms, 
frequent night-time symptoms, FEV1 ≤ 60%, and/or variation 
in MEP higher than 30% were classified with severe persistent 
asthma.16
Fetal well-being was assessed through antenatal cardio-
tocography, fetal biophysical profile (BPP), and Doppler 
velocimetry of umbilical arteries. Patients were submitted 
to tests in the same period of the prenatal visit, in the third 
trimester of pregnancy. In this research, the results of the 
last evaluation performed up to two weeks before birth 
were analyzed. BPP parameters were evaluated through 
ultrasonography (tone, fetal body movements, fetal breathing 
movements, and amniotic fluid volume). The ultrasound 
equipment used was Toshiba® model SSA-220A and Philips® 
model Envisor; and a Hewllet Packard® cardiotocography 
machine. The results of cardiotocography were classified 
pursuant to the clinical protocol, which classifies an active 
fetus as normal when the window shows at least two transient 
accelerations of 15 bpm of amplitude within a 30-minute 
window, baseline fetal heart rate (FHR) between 110 and 
Characteristics n (%)
Maternal age (years), average (SD) 26.7 (6.6)
White 76 (65.0)
Nulliparous 41 (35.0)
Asthma complications in the second trimester 46 (39.3)
Asthma complications in the third trimester 44 (37.6)
Systemic corticosteroid therapy for asthma 21 (17.9)
Complications
 Fetal growth restriction 14 (11.9)
 Pneumonia 11 (9.4)
 Urinary infection/pyelonephritis 6 (5.1)
 Preeclampsia 4 (3.4)
 Premature rupture of membranes 10 (8.5)
 Gestational diabetes 3 (2.5)
 Placental abruption 4 (3.4)
Severity of asthma, n (%)
 Intermittent 41 (35.0)
 Mild persistent 33 (28.2)
 Moderate persistent 21 (17.9)
 Severe persistent 22 (18.8)
Doppler velocimetry of the umbilical artery (n = 28)
 A/B ratio, average (SD) 2.50 (0.37)
 Pulsatility index, average (SD) 0.91 (0.18)
Type of birth
 Vaginal delivery without medical instruments 27 (23.1)
 Forceps 13 (11.1)
 Cesarean section 77 (65.8)
Complications during labor/postpartum, n (%)
 Asthma attack 10 (8.6)
 Atony 2 (1.7)
 Surgical wound infection 1 (0.9)
 Corticosteroid therapy during labor, n (%) 24 (20.5)
 Gestational age at birth (weeks), average (SD) 38.6 (1.9)
 Weight of the newborn (g), average (SD) 3,056 (581)
Gender of the newborn, n (%)
 Female 61 (52.1)
 Male 56 (47.9)
 1 min Apgar score < 7, n (%) 3 (2.6)
 5 min Apgar score < 7, n (%) 0 (0)
Table 1 – Characteristics of pregnancies complicated 
by maternal asthma.
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160 bpm, variability greater than 5 bpm, and absence of 
decelerations. Fetuses with abnormal cardiotocography tracings 
were designated as hypoactive fetus or inactive fetus. Amniotic 
fluid volume was assessed through amniotic fluid index (AFI), 
and the values were classified as normal when higher than 
5.0 cm. For Doppler velocimetry of umbilical arteries, the 
insonation of the umbilical cord segment was close to the 
placental insertion site and was performed in the absence of 
fetal body and breathing movements. The recording of at least 
three sonograms with a minimum of five uniform sound waves 
was deemed satisfactory. A/B ratios (systole/diastole ratio) and 
pulsatility index (PI) were calculated. Values obtained were 
compared with the normality curve for that vessel.17
The following clinical, obstetrical, and perinatal variables 
were assessed: respiratory complications in the second and 
third trimester, need for systemic corticosteroid therapy 
during pregnancy, systemic corticosteroid therapy at birth, 
obstetric complications, type of birth, how labor was triggered 
(spontaneous labor, labor induction, or elective cesarean 
section), complications during birth or postpartum (uterine 
atony, infections, exacerbation of asthma), gestational age at 
birth, newborn weight and adequacy, newborn gender, and 
Apgar score from 1 to 5 minutes.
Gestational age was calculated from the last menstrual 
period (LMP), when compatible with the gestational age 
estimated by ultrasonography performed no later than the 
20th week of pregnancy. In cases in which such correlation was 
not observed, the gestational age was calculated through data 
from the first ultrasonography. The weight of the newborn, in 
grams, measured in the delivery room, was compared with the 
normality curve of Alexander et al.,18 in a way that the newborns 
with weight below the 10th percentile of the corresponding range 
were classified as small for the gestational age. 
Results were analyzed by using the Medcalc software 
(Medcalc, version 11.5.1.0). Categorical variables were analyzed 
in a descriptive manner, by calculating absolute and relative 
frequencies. In order to analyze the continuous variables, the 
results were expressed in averages and standard deviations. 
The chi-squared test was used to compare proportions and, 
when applicable, Fisher’s exact test. The ANOVA test was used 
to compare the averages among the groups for variables with 
normal distribution, and the Kruskal-Wallis test was used for 
abnormally distributed variables. The value of 0.05 (alpha = 5%) 
was adopted as the significance level, and descriptive levels (p) 
below this value were deemed significant (p < 0.05).
Results
A total of 117 pregnancies complicated by maternal asthma 
were included in the case selection. Maternal characteristics, 
birth information, and perinatal outcomes are presented in 
Table 1. Regarding the distribution of the cases pursuant 
to severity of the disease, the higher proportion of cases 
classified as intermittent is notable. Cases of severe asthma 
corresponded to 19% of the sample, and only one patient 
of this group needed to be hospitalized in an intensive care 
unit (ICU) due to disease exacerbation. The most frequent 
obstetric complication was fetal growth restriction, suspected 
in the antenatal period in 12% of the cases. Regarding the type 
of birth, cesarean section was the most frequent (65.8%). In 
postpartum, there was exacerbation of the disease in 8.6% of 
the patients. 
Of all study cases, 90 (76.9%) pregnant women were 
submitted to evaluation of antepartum fetal well-being. Results 
are presented in Table 2. The cardiotocography showed normal 
results (active fetus) in the majority of the cases; the same was 
observed regarding fetal BPP. The diagnosis of oligohydramnios 
occurred in four of 90 cases (4.4%). Doppler velocimetry of 
umbilical arteries showed normal results in all cases in which 
this test was performed (n = 28, 23.9%).
Table 3  presents the comparison of the main study 
parameters in different groups categorized pursuant to the 
severity of maternal asthma. During the prenatal period, 
respiratory complications were similar in the groups analyzed. 
In the second and third trimesters, these complications were 
observed in at least 30% of the cases in each group. The need 
for maternal corticosteroid therapy during prenatal period was 
 
Result Intermittent  
(n = 32)
Mild persistent  
(n = 25)
Moderate persistent  
(n = 16)
Severe persistent  
(n = 17)
p 
Cardiotocography
 Active 27 (84.4) 25 (100) 14 (87.5) 16 (94.1) 0.197
 Hypoactive  5 (15.6)  0 (0)  2 (12.5)  1 (5.9)
Fetal biophysical profile
 10 24 (75.0) 21 (84.0) 13 (81.3) 12 (70.6)
  8  7 (21.9)  4 (16.0)  3 (0.19)  5 (29.4) 0.806
  6  1 (3.1)  0 (0)  0 (0)  0 (0)
AFI
 ≥ 5.0 cm 31 (96.9) 24 (96.0) 16 (100) 15 (88.2) 0.387
 < 5.0 cm  1 (3.1)  1 (4.0)  0 (0)  2 (11.8)
 AFI, average (SD) 10.1 (4.9-19.0) 11.2 (4.9-17.3) 11.8 (5.6-25.0) 9.7 (3.2-15.6) 0.130
SD, standard deviation; AFI, amniotic fluid index.
Table 2 – Assessment of fetal well-being according to severity of maternal asthma
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significantly different in the study groups, with higher use of 
systemic corticosteroids in the groups of pregnant women 
with moderate persistent and severe persistent asthma. The 
analysis of data on the beginning of labor in different groups 
shows that elective cesarean section was more often indicated 
in cases showing greater severity and, conversely, spontaneous 
labor occurred more often in cases of intermittent and mild 
persistent asthma. However, when analyzing the types of 
birth that effectively occurred, there was a high proportion 
of cesarean sections in all groups. There was no difference 
regarding fetal distress during labor. The use of systemic 
corticosteroids during labor showed a significant difference 
among the groups, with higher frequency in the group with 
severe persistent asthma. No difference was noted in perinatal 
outcomes among the study groups.
Discussion
Occurrence of perinatal complications in pregnancies 
complicated by asthma did not show significant differences 
among the groups categorized by the severity of the maternal 
disease. However, it was verified that, in cases of greater 
severity, there was a higher proportion of cases in which 
the elective cesarean section was performed before the 
beginning of labor, in order to end the pregnancy, which may 
have contributed to similar perinatal outcomes in all groups 
analyzed. 
There are conflicting results regarding the impact of asthma 
on pregnancy. Studies indicate association of the disease with 
small for gestational age (SGA) or underweight newborns, 
in addition to prematurity,5,9,10,11,14 especially related to 
the severity of the disease. However, in a meta-analysis 
performed by Murphy et al.,4 no increased risk was verified 
for these adverse events. The present study also did not verify 
association between the severity of asthma and adverse 
prenatal outcomes, with preserved fetal well-being, which 
may be explained, in part, by the control of the maternal 
disease and by the active decision to end the pregnancy. 
Fetal growth restriction was verified in 11.9% of the cases, 
although there were no cases of abnormality in the Doppler 
velocimetry of the umbilical artery. The mechanism by which 
reduction in fetal growth occurs is not fully established. The 
placental physiology appears to suffer changes in pregnancies 
complicated by maternal asthma, due to the reduced activity 
of the 11-beta-hydroxysteroid dehydrogenase type 2 enzyme 
in pregnancies with female fetuses.19 This enzyme appears to 
protect the fetus against the excess of maternal glucocorticoids, 
and influences fetal growth.20 Prospective studies addressing 
changes in placental flow and in enzyme expression in the 
placenta may clarify theses aspects. 
In cases that assessed fetal well-being through a BPP, 
only one showed a suspicious result during the antepartum 
period. Also, no difference was found in the proportion of cases 
developing intrapartum fetal distress in the groups formed 
pursuant to severity of maternal asthma. In a study comparing 
 
Result Intermittent  
(n = 41)
Mild persistent  
(n = 33)
Moderate persistent  
(n = 21)
Severe persistent  
(n = 22)
p 
Maternal age (years), average (SD) 25.7 (7.5) 27.2 (6.5) 29.5 (5.7) 25.1 (5.2) 0.097
White, n (%) (51.2) 23 (69.7) 14 (66.7) 18 (81.8) 0.090
Nulliparous, n (%) 17 (41.5) 12 (36.4) 3 (14.3) 9 (40.9) 0.065
Pulmonary complications
 Second trimester 13 (31.7) 12 (36.4) 12 (57.1) 9 (40.9) 0.269
 Third trimester 15 (36.6) 12 (36.4) 8 (38.1) 9 (40.9) 0.986
Systemic corticosteroid therapy, n (%) 2 (4.9) 3 (9.1) 6 (28.6) 10 (45.5) < 0.001
Beginning of labor
 Spontaneous labor 21 (51.2)      15 (45.1) 4 (19.0) 7 (31.8)
 Labor induction 11 (26.8) 10 (30.3) 6 (28.5) 3 (13.6) 0.039
 Cesarean section 9 (21.9) 8 (24.2) 11 (52.5) 12 (54.6)
Type of birth
 Vaginal delivery without medical instruments 11 (26.8) 9 (27.2) 2 (9.5) 4 (18.2)
 Forceps 5 (12.3) 5 (15.3) 3 (14.3) 1 (4.6) 0.459
 Cesarean section 25 (60.9) 19 (57.5) 16 (76.2) 17 (77.2)
Intrapartum fetal distress 6 (9.8) 3 (9.1) 3 (9.5) 1 (4.5) 0.904
Corticosteroid therapy during labor, n (%) 2 (4.8) 8 (24.2) 4 (19.4) 10 (45.4) < 0.001
GA at birth (weeks), average (SD) 38.5 (1.86) 38.75 (1.98) 38.72 (2.25) 38.14 (1.64) 0.700
Weight of the newborn (g), average (SD) 3,102.4 (592.1) 2,979.3 (561.7) 3,265.7 (704.9) 2,884.0 (395.9) 0.138
SGA newborn 9 (22.0) 4 (12.1) 2 (9.5) 4 (18.2) 0.541
1 min Apgar score < 7, n (%) 2 (4.8) 1 (3.0) 0 (0) 0 (0) 0.591
Gender of the newborn
 Female 22 (53.7) 16 (48.5) 10 (47.6) 13 (59.1) 0.847
 Male 19 (46.3) 17 (51.5) 11 (52.4) 9 (40.9)  
GA, gestational age; SGA, small for gestational age.
Table 3 – Complications during pregnancy, birth information and perinatal outcomes according to severity of maternal 
asthma
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antenatal cardiotocography in pregnant patients with asthma 
and pregnant patients without comorbidities, no significant 
difference was found in FHR parameters, although a difference 
in the patterns of fetal movement was observed, indicating 
that the counting of fetal movements may be a useful method 
to assess fetal well-being.21 Cesarean section was chosen in 
66% of the cases, a higher proportion than that described in 
high-risk pregnancies monitored in this hospital (57%).22
Regarding respiratory complications during the prenatal 
period, they may result from aggravation of the disease by 
the increased intra-abdominal pressure, in addition to higher 
oxygen consumption by the maternal organism.23 Treatment of 
asthma is based, mainly, on inhaled corticosteroids. And, when 
the clinical condition is aggravated, inhaled corticosteroid 
dosages are adjusted, and it is also possible to associate it with 
other medications, such as long-acting beta-agonists and oral 
systemic corticosteroids, for improved control of the condition. 
As to intermittent conditions or exacerbations, oxygenation 
and short-acting beta-agonists are the most used. In cases of 
more severe and poorly controlled attacks, oral corticosteroids 
may be used.20
The incidence of pneumonia in pregnancy does not appear 
to differ from the general population of non-pregnant women. 
However, asthma may be a predisposing factor, as this 
maternal disease is reported in 46.4% of the cases in which 
pneumonia was diagnosed during pregnancy.24 In the present 
study, pneumonia was reported in 9.4% of the cases analyzed. 
There are studies showing that, during pregnancy, drug 
treatment of asthma does not result in adverse effects on 
pregnant women and fetuses, instead benefiting both by 
controlling the disease.9,13,14 In this study, prenatal maternal 
corticosteroid therapy was used in higher proportion in the 
group with severe asthma, which may have contributed to 
improve the control of the maternal disease and to a better 
perinatal outcome. Similarly, Dombrowski et al.14 found no 
statistically significant difference for perinatal complications, 
except for neonatal sepsis, and maternal complications among 
pregnant women without asthma and pregnant women with 
asthma, but they found a significant difference as to the 
incidence of cesarean births.
Asthma is a disease with variable course that may present 
variations in severity. Therefore, the physician should be 
aware of the clinical and functional parameters at all times. 
If a pregnant woman shows asthma controlled for more than 
three weeks, medication should be reduced. But when the 
disease is partially controlled, non-controlled or aggravated, an 
increase in medication should be considered. Discontinuation 
of the treatment during pregnancy may contribute to worsen 
the maternal condition, and this is reported in the study by 
Lim et al.,25 in which 25.8% of the study professionals would 
reduce or discontinue the medication previously used, even 
during asthma attacks. In the present study, patients had their 
medications adjusted in cases of aggravation of the disease, and 
were oriented as to environmental measures, such as: avoid 
contact with pollen, mold, mites, occupational sensitizers, cold 
air, physical exercises, respiratory infections, and smoking. 
Therefore, this study evidences that the benefit of having 
asthma controlled during pregnancy exceeds any potential 
harm resulting from the medications used to control the disease.
Despite the efforts used to keep asthma controlled, exacer-
bations may occur. There are several factors that may trigger it, 
such as: discontinuation of medication, exposure to allergens, 
stress, and respiratory tract infection. While prevention is 
the most suitable conduct to avoid exacerbations, Schatz et 
al.26 evidenced that 52% of the patients with severe asthma 
showed exacerbation of the disease during pregnancy, and 
many of them needed hospitalization. 
Therefore, it is important that obstetricians properly 
recog nize, conduct, and treat severe cases.27 Treatment 
stra tegies are based on additional oxygenation, so that satu-
ration remains above 95%; short-acting beta-agonists and 
corticosteroids; prevention and correction of hypoxemia; 
or reduction of hypercapnia.28 In this study, no pregnant 
woman showed to be immune to the medical treatment 
of asthma indicating the need for an emergency cesarean 
section.
Improvement in the exacerbation of severe asthma after 
birth results from two concomitant factors: intra-abdominal 
pressure reduction and oxygen consumption reduction.29 Birth 
treatment in patients with asthma should be cautious, even 
in the absence of exacerbations. Continuous-use medications 
to control the disease should not be delayed or discontinued 
due to labor. In this study, patients showing exacerbation were 
medicated with systemic corticosteroid at the moment of labor 
and of birth. Only one pregnant woman with severe asthma 
needed support in the intensive care unit (for seven days), and 
birth was performed with general anesthesia.
The limitations of this study include the restricted number 
of cases with Doppler velocimetry assessment, and the 
difficulty in obtaining information due to the retrospective 
characteristic of the work. Additionally, a control group of 
pregnant women without asthma in the same period was not 
obtained, given that this hospital primarily attends to high-risk 
pregnancies.
Conclusion
Severity of maternal asthma does not appear to have any direct 
influence on perinatal outcomes and does not compromise 
fetal well-being. Although the exacerbation of asthma during 
pregnancy is not related to the severity of the disease, poorly 
controlled asthma during pregnancy may pose risks of adverse 
perinatal outcome. Active conduct to enable a better maternal 
clinical condition provides a favorable prognosis for pregnancy 
complicated by asthma.
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